Alpelisib (BYL719)
- CAS No.
- 1217486-61-7
- Chemical Name:
- Alpelisib (BYL719)
- Synonyms
- Alpelisib;Piqray;BYL-719;CS-614;100803;BLV-719;BYL-719 /BYL719;Alpelisib (BYL719);BYL-719(Alpelisib);Alpelisib (BLY-719
- CBNumber:
- CB52604234
- Molecular Formula:
- C19H22F3N5O2S
- Molecular Weight:
- 441.47
- MOL File:
- 1217486-61-7.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/7/2 8:55:11
Density | 1.391 |
---|---|
storage temp. | Store at -20°C |
solubility | ≥22.07 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH |
form | White solid. |
pka | 6.29±0.70(Predicted) |
color | Off-white to light yellow |
InChIKey | STUWGJZDJHPWGZ-LBPRGKRZSA-N |
SMILES | N1(C(NC2=NC(C)=C(C3C=CN=C(C(C)(C)C(F)(F)F)C=3)S2)=O)CCC[C@H]1C(N)=O |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS08 |
---|---|
Signal word | Danger |
Hazard statements | H373 |
Precautionary statements | P260-P314-P501 |
HS Code | 29341000 |
Alpelisib (BYL719) Chemical Properties,Uses,Production
Description
BYL719 is an inhibitor of phosphoinositide 3-kinase α (PI3Kα; IC50s = 4.6, 4, and 4.8 nM for wild-type, E545K mutant, and H1047R mutant PI3K, respectively). It is selective for PI3Kα over PI3Kβ, PI3Kδ, PI3Kγ, and PI4Kβ (IC50s = 1,156, 290, 250, and 581 nM, respectively), as well as VPS34, mTOR, DNA-PK, and ATR (IC50s = >9,100 nM for all). BYL719 (12.5, 25, and 50 mg/kg) reduces tumor volume in a PI3Kα-dependent Rat1-myr-p110α mouse xenograft model. It also reduces tumor burden in THP-1 acute myeloid leukemia (AML) and MCF-7 breast cancer mouse xenograft models. Formulations containing BYL719 have been used in the treatment of advanced or metastatic breast cancer.
brand name
Piqray
General Description
Class: lipid kinase; Treatment: breast cancer; Other name: NVP-BYL719; Elimination half-life = 13.7 h; Protein binding = 89%
Alpelisib (BYL719) Preparation Products And Raw materials
Raw materials
1of3
chevron_rightPreparation Products
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
A.J Chemicals | 91-9810153283 | New Delhi, India | 6124 | 58 | Inquiry |
Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
Taj Mahal Vision Chemicals Private Limited | 07942557933 | Mumbai, India | 206 | 58 | Inquiry |
SynZeal Research Pvt Ltd | +1 226-802-2078 | Gujarat, India | 6522 | 58 | Inquiry |
Pharma Affiliates | 172-5066494 | Haryana, India | 6761 | 58 | Inquiry |
Wuhan Fortuna Chemical Co., Ltd | +86-027-59207850 | China | 5999 | 58 | Inquiry |
Zibo Hangyu Biotechnology Development Co., Ltd | +86-0533-2185556 +8617865335152 | China | 11027 | 58 | Inquiry |
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD. | +86-18600796368 +86-18600796368 | China | 49 | 58 | Inquiry |
Hangzhou FandaChem Co.,Ltd. | 008657128800458; +8615858145714 | China | 9338 | 55 | Inquiry |
Related articles
- An orally PI3K inhibitor: Alpelisib
- Alpelisib -an orally available phosphatidylinositol 3-kinase (PI3K) inhibitor with specific activity against PI3K alpha (PI3Kα....
- Jan 17,2024
1217486-61-7( Alpelisib (BYL719))Related Search:
1of4
chevron_right